AzTrials
AzTrials

Palliative CareNCT06871241

Public Awareness and Understanding of PC in the UAE

An observational study of Palliative Care, run by Burjeel Medical City at 1 site in United Arab Emirates.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Palliative care (PC) is essential medical care for improving the quality of life for patients with life-threatening illnesses and their families. There has been substantial evolution of PC services in the United Arab Emirates (UAE), yet public awareness regarding PC remains shallow, hindering its utilization and… Read more about this study

Who is it for?
Ages 14 years and olderHealthy volunteers can take part
Conditions the study is for
Palliative Care
How many people
824 participants
Where
1 siteUnited Arab Emirates
Study dates
25 Jul 2024to 15 Jan 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 14 years and older
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Study population: The target population included residents of the UAE, both Emiratis and expatriates, who could read and respond in either English or Arabic.

Who may be able to join

  • UAE residents
  • Provided informed consent to participate
  • Completed the survey in either Arabic or English

Who cannot join

  • Non-UAE residents
  • Incomplete survey responses (if applicable)

Trial locations and contacts

1 site in 1 country.

United Arab Emirates1 site
  • Burjeel Cancer Institute

    Abu Dhabi, Abu Dhabi Emirate

Other trials in United Arab Emirates

About this study

Official title: Public Awareness and Understanding of Palliative Care in the United Arab Emirates: Insights from a Population-Based Cross-Sectional Study

Palliative care (PC) is essential medical care for improving the quality of life for patients with life-threatening illnesses and their families. There has been substantial evolution of PC services in the United Arab Emirates (UAE), yet public awareness regarding PC remains shallow, hindering its utilization and acceptance on a large scale.

Read the detailed description

This study aimed to evaluate public perceptions and awareness of PC in the UAE. A cross-sectional survey was conducted in both Arabic and English. This study emphasizes the need of addressing these gaps to integrate PC effectively into the UAE healthcare system, ensuring equitable access and improved quality of life for patients and their families.

Conditions
Palliative Care
Keywords
Supportive care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Familiarity and Understanding of Palliative and Supportive Care as Measured by a Structured Survey

    The study assessed participants' awareness, familiarity, and understanding of palliative and supportive care through a structured questionnaire. The survey includes Likert-scale and multiple-choice questions designed to evaluate:

    • Self-reported familiarity with palliative and supportive care concepts
    • Knowledge of available palliative care services
    • Perceived importance of palliative care in the healthcare system
    • Disparities in responses between Arabic-speaking and English-speaking groups.

    Responses were analyzed quantitatively by calculating the proportion of participants at different familiarity levels i.e., Very familiar, somewhat familiar, Neutral/not sure, not very familiar, not familiar at all and comparing trends across language groups. Percentages were calculated and categorical responses were summarized using frequency distributions.

    Measured: Surveys were conducted in Arabic from July 25, 2024, to August 18, 2024, and in English from August 5, 2024, to August 18, 2024.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Mar 2025
  2. Study start25 Jul 2024
  3. Primary completion18 Aug 2024
  4. Study completion15 Jan 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
824 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06871241
Sponsor's protocol ID
BH/REC/073/24
Status last verified
Feb 2025
First submitted
3 Feb 2025
Last updated
11 Mar 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: The individual participant data (IPD) from this study will not be publicly disclosed due to confidentiality concerns. However, aggregated data supporting the findings of this study may be available from the corresponding author upon reasonable request, subject to institutional and ethical approvals.

Questions about this trial

What is this clinical trial studying?

An observational study of Palliative Care, run by Burjeel Medical City at 1 site in United Arab Emirates.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Arab Emirates. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Familiarity and Understanding of Palliative and Supportive Care as Measured by a Structured Survey (time frame: Surveys were conducted in Arabic from July 25, 2024, to August 18, 2024, and in English from August 5, 2024, to August 18, 2024.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Mar 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in